An oral chemotherapy cycle management program offers clinical support, reduces medication wastage, and provides management of adverse effects to realize cost savings for payers and patients.
Elan Rubinstein, MPH, PharmD
Advertisement
Articles by Elan Rubinstein, MPH, PharmD
Advertisement
Latest Updated Articles
- Impact of Clinical Oral Chemotherapy Program on Wastage and Hospitalizations
Published: May 16th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
4
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
5
